![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/506 | (2006.01) |
C07C 309/30 | (2013.01) | ||
C07D 403/04 | (2006.01) | ||
C07C 309/04 | (2013.01) | ||
C07C 55/22 | (2006.01) | ||
A61P 35/04 | (2018.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
C07C 309/04 | (2006.01) | ||
C07B2200/13 | (2013.01) | ||
C07C 309/30 | (2006.01) | ||
C07D 403/04 | (2013.01) | ||
C07C 59/265 | (2013.01) |
(11) | Number of the document | 3471730 |
(13) | Kind of document | T |
(96) | European patent application number | 17814169.3 |
Date of filing the European patent application | 2017-06-16 | |
(97) | Date of publication of the European application | 2019-04-24 |
(45) | Date of publication and mention of the grant of the patent | 2021-10-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/037872 |
Date | 2017-06-16 |
(87) | Number | WO 2017/218892 |
Date | 2017-12-21 |
(30) | Number | Date | Country code |
201662351749 P | 2016-06-17 | US |
(72) |
GRECO, Michael, Nicholas , US
COSTANZO, Michael, John , US
GREEN, Michael, Alan , US
PENG, Jirong , US
WILDE, Victoria, Lynn , US
ZHANG, Don , US
|
(73) |
Beta Pharma, Inc. ,
1000 N. West Street
Suite 1200, Wilmington, DE 19801,
US
|
(54) | PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF |
PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF |